RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Houston, TX · San Antonio, TX · +21 more sites
Lung Cancer clinical trials in San Antonio, TX
32 recruiting lung cancer studies with a site in San Antonio, TX.
RecruitingPhase 1 / Phase 2NCT07038343
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Sponsor: Avenzo Therapeutics, Inc.
Dallas, TX · Houston, TX · San Antonio, TX · +16 more sites
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Austin, TX · Dallas, TX · +42 more sites
RecruitingPhase 1NCT07462377
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Sponsor: EpiBiologics
Houston, TX · San Antonio, TX · +4 more sites
RecruitingPhase 1 / Phase 2NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Sponsor: Institut de Recherches Internationales Servier
Houston, TX · San Antonio, TX · +19 more sites
RecruitingPhase 1 / Phase 2NCT07070232
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Sponsor: BioNTech SE
Houston, TX · San Antonio, TX · +17 more sites
RecruitingPhase 2 / Phase 3NCT07100080
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Sponsor: Bristol-Myers Squibb
Houston, TX · San Antonio, TX · +26 more sites
RecruitingPhase 3NCT06216301
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Sponsor: NovoCure GmbH
Dallas, TX · Edinburg, TX · +35 more sites
RecruitingPhase 1NCT07164313
A Study of ZW251 in Participants With Advanced Solid Tumors
Sponsor: Zymeworks BC Inc.
Houston, TX · San Antonio, TX · +6 more sites
RecruitingPhase 3NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Sponsor: Bristol-Myers Squibb
Amarillo, TX · Austin, TX · Denton, TX · +35 more sites
RecruitingPhase 3NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Sponsor: Bristol-Myers Squibb
Galveston, TX · Houston, TX · San Antonio, TX · +38 more sites
RecruitingPhase 1NCT07705035
DBC-664 in Adult Patients With Solid Tumors
Sponsor: Duboce Biopharmaceuticals, Inc.
San Antonio, TX · +5 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Austin, TX · Houston, TX · Irving, TX · +15 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
Dallas, TX · Houston, TX · +21 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Dallas, TX · Edinburg, TX · Forth Worth, TX · +30 more sites
RecruitingPhase 1NCT05245500
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Sponsor: Bristol-Myers Squibb
Dallas, TX · Fort Worth, TX · Houston, TX · +22 more sites
RecruitingPhase 1NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Sponsor: Nammi Therapeutics Inc
San Antonio, TX · +9 more sites
RecruitingPhase 1NCT06586515
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
Houston, TX · San Antonio, TX · +23 more sites
RecruitingPhase 1 / Phase 2NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Sponsor: Marengo Therapeutics, Inc.
Houston, TX · San Antonio, TX · +11 more sites
RecruitingPhase 1NCT06910657
IDOV-Immune for Advanced Solid Tumors
Sponsor: ViroMissile, Inc.
Houston, TX · San Antonio, TX · +1 more sites
RecruitingPhase 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Sponsor: Jazz Pharmaceuticals
Amarillo, TX · Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Houston, TX · +103 more sites
RecruitingPhase 1NCT07300150
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Sponsor: PAQ Therapeutics, Inc.
San Antonio, TX · +3 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Austin, TX · Dallas, TX · Fort Worth, TX · +8 more sites
RecruitingPhase 1NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Dallas, TX · Houston, TX · San Antonio, TX · +13 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Austin, TX · Dallas, TX · Houston, TX · +18 more sites
RecruitingPhase 1NCT07424547
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Austin, TX · San Antonio, TX · +3 more sites
RecruitingPhase 1 / Phase 2NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Sponsor: Frontier Medicines Corporation
Houston, TX · Kingwood, TX · San Antonio, TX · +12 more sites
RecruitingPhase 1 / Phase 2NCT06956690
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Sponsor: Hummingbird Bioscience
Dallas, TX · San Antonio, TX · +3 more sites
RecruitingPhase 1 / Phase 2NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Tasca Therapeutics
Dallas, TX · San Antonio, TX · +11 more sites
RecruitingPhase 1 / Phase 2NCT07148128
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Sponsor: Auricula Biosciences Inc.
Dallas, TX · San Antonio, TX
RecruitingPhase 1NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Sponsor: Dren Bio
Austin, TX · Dallas, TX · San Antonio, TX · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.